STOCK MARKET BSE NSE

COVID-19 vaccine found to be 94.5% effective, says US biotech firm Moderna

Published: 17th November 2020 04:59 PM  |   Last Updated: 17th November 2020 05:00 PM  

The race to develop a #Covid19 vaccine picked up pace on Monday with US biotech firm Moderna announcing its candidate was 94.5% effective in interim analysis of its phase 3 trials, which involved more than 30,000 volunteers.


Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

IPL_2020
flipboard facebook twitter whatsapp